Transaction overview
Shore Capital Partners announced the merger of Reliant Healthcare and Care Fusion Rx to form a leading national infusion therapy platform. The deal closed on November 20, 2025, though financial details such as equity split and total enterprise value remain undisclosed. Reliant Healthcare is an established provider of home and ambulatory infusion therapies in Louisiana, Texas, and Oklahoma with 14 ambulatory infusion centers (AICs) and multiple specialty pharmacies. Care Fusion Rx, founded more recently in 2020, specializes in complex therapies from its base in California and focuses on chronic IVIG treatments.
Deal structure and financing
The exact equity-debt split for the merger is not disclosed, but Houlihan Lokey and Guggenheim Securities acted as financial advisors to Shore Capital Partners. The transaction was supported by a syndicate of banks providing necessary debt funding, although specific leverage metrics are unknown. Covington Associates advised Care Fusion Rx on its divestiture, while Brentwood Capital guided Reliant Healthcare through the merger process. Additionally, DLA Piper, McDermott Will & Emery, and Quarles & Brady served as legal counsel for Shore, with Polsinelli representing Care Fusion.
Strategic context
Shore Capital Partners sought to expand its healthcare portfolio by consolidating complementary infusion therapy providers into a national platform. Reliant's established market presence in the southern United States combined with Care Fusion Rx's expertise in complex therapies and strong footprint on the West Coast creates a unified entity capable of delivering comprehensive services across both home and ambulatory settings. This merger aims to enhance patient access to high-quality, cost-effective care while optimizing operational efficiency.
Regulatory path
The transaction was reviewed by the U.S. Federal Trade Commission (FTC) and Antitrust Division of the Department of Justice (DOJ), though no specific remedies were required due to the non-overlapping geographic markets of Reliant Healthcare and Care Fusion Rx. Given the healthcare sector's regulatory scrutiny, particularly in consolidation deals involving patient care services, both parties complied with Hart-Scott-Rodino Act filing requirements. The combined entity is well-positioned to navigate future regulatory landscapes as it expands its service offerings nationally.